Aptamers Market .

Aptamers Market rising to a value of US$4.3 bn by 2019.
The growing use of aptamers in drug discovery, pharmaceutical studies, as well as disease treatment
will help drive the global aptamers market through the current decade, says Transparency Market
Research in a recent study. The report is titled ‘Aptamers Market - Global Industry Analysis, Size,
Share, Growth, Trends and Forecast, 2013 - 2019.’ According to the report, the global aptamers
market was valued at US$93.0 million in 2012, and it is expected that the market will reach a
valuation of US$4,333.0 million by 2019. This translates to a remarkable CAGR of 73.1% between
2013 and 2019.
Read Report overview @ https://www.transparencymarketresearch.com/aptamers-market.html
However, the report also warns that the growth in the global aptamers market will be restrained to
some extent ethical issues associated with aptamers derived from animals. This drawback will be
further compounded by strict regulatory mandates designed around aptamers. However, these
drawbacks can be overcome by companies in the global aptamers market by modifying aptamers
chemistry. For instance, animal-derived aptamers can be replaced by aptamers obtained via the invitro process.
For the purpose of this study, the global aptamers market is segmented on the basis of types,
applications, and geography. The types of aptamers studied in the report include peptide and nucleic
acid aptamers. The segment of nucleic acid aptamers was not only the largest as of 2012, but is also
expected to be the fastest growing over the report’s forecast period. This is chiefly owing to the
widespread use of nucleic acid aptamers in the R&D sector.
Likewise, the applications analyzed in the report are: Diagnostics, therapeutics development,
research and development, and others. Of these, the diagnostics segment will report consistent
growth over the next four years as the demand for aptamers for biomedical diagnostics, biomarker
development, and molecular imaging remains steady. However, in terms of pace of growth,
therapeutics development applications will outpace all other application segments over the report’s
forecast period.
From the geographical standpoint, the aptamers market for the following regions is studied: North
America, Asia Pacific, Europe, and Rest of the World. Thanks to several key players in the aptamers
market being based in the United States, the North America region was identified as the largest
market for aptamers in 2012. This factor also creates an environment that fosters R&D related to
aptamers.
Request Sample Report@ https://www.transparencymarketresearch.com/sample/sample.php?
flag=S&rep_id=1335
The Europe aptamers market was the second largest from the global standpoint. According to the
findings of the report, Europe constituted about 35% of the global aptamers market in 2012. Small
scale industries play a key role in keeping the Europe aptamers market firmly on the growth track.
The Asia Pacific market is currently brimming with opportunities in diagnostics and
pharmaceuticals, enabling the region to post the highest CAGR between 2013 and 2019.
TMR’s report also conducts a detailed analysis of the competitive scenario in the global aptamers
market, which is characterized by intense competition. A high degree of competition has stimulated
higher investments the development of novel aptamers. Leading market participants include:
Somalogic, Inc., Aptamer Science, Inc. NOXXAN Pharma AG, and Aptagen, Inc.

Download Report